Table 4. FMD (flow-mediated dilation), baseline diameter of brachial artery, maximal diameter of brachial artery, SBP (systolic blood pressure), DBP (diastolic blood pressure), and HR (heart rate) at enrollment and 6.9 months thereafter.

	Cilostazol (+) (n = 22)			Cilostazol (−) (n = 22)
	Enrollment	At 6–9 months	P-value	Enrollment	At 6–9 months	P-value
FMD, %	5.2 (3.8–8.5)	5.4 (4.2–6.7)	0.29	5.0 (3.6–6.4)	4.9 (4.0–7.0)	0.38
baseline diameter, mm	4.2 ± 0.7	4.4 ± 0.7	0.18	4.1 ± 0.6	3.9 ± 0.5	0.10
maximal diameter, mm	4.5 ± 0.7	4.6 ± 0.7	0.22	4.3 ± 0.7	4.1 ± 0.5	0.05
SBP, mmHg	125 ± 16	131 ± 16	0.15	125 ± 17	130 ± 19	0.28
DBP, mmHg	69 ± 7	73 ± 11	0.21	69 ± 13	70 ± 10	0.74
HR, n/min	67 ± 11	65 ± 12	0.64	70 ± 10	67 ± 8	0.20